Page 15 - Index

Antipsychotic
Risperidone Oral Solution
1mg/ml
PRODUCT DESCRIPTION
•
Risperidone Oral Solution
STRENGTH
1mg/ml
PACK SIZE
100ml
INDICATIONS
Risperidone is indicated for:
•
the treatment of schizophrenia.
•
the treatment of moderate to severe
manic episodes associated with bipolar
disorders.
•
the short-term treatment (up to 6
weeks) of persistent aggression in
patients with moderate to severe
Alzheimer’s dementia unresponsive
to non-pharmacological approaches
and when there is a risk of harm to
self or others.
the short-term symptomatic treatment
(up to 6 weeks) of persistent aggression
in conduct disorder in children from
the age of 5 years and adolescents with
subaverage intellectual functioning or
mental retardation.
S
U
I
T
A
B
L
E
F
O
R
S
U
G
A
R
E
T
H
A
N
O
M
A
D
E
I
N
L
T
H
E
O%
D
I
A
B
E
S
T
I
C
F
R
E
E
F
R
E
E
U
K
S
U
I
T
A
B
L
E
V
E
G
E
T
A
F
O
R
S
N
R
I
A
Click here for 
Prescribing Information
Antipsychotic
Trifluoperazine Oral Solution
5mg/5ml
PRODUCT DESCRIPTION
Trifluoperazine Oral Solution
STRENGTH
5mg/5ml
PACK SIZE
150ml
INDICATIONS
Low Dosage - Trifluoperazine is indicated
as an adjunct in the short term management
of anxiety states, depressive symptoms
secondary to anxiety, and agitation. It is also
indicated in the symptomatic treatment of
nausea and vomiting.
High Dosage - Trifluoperazine is indicated
for the treatment of symptoms and
prevention of relapse in schizophrenia
and in other psychoses, especially of the
paranoid type, but not in depressive
psychoses. It may also be used as an
adjunct in the short term management
of severe psychomotor agitation and
of dangerously impulsive behaviour, for
example, mental subnormality.
S
U
I
T
A
B
L
E
D
I
A
F
O
R
B
E
T
I
C
S
S
E
I
N
A
E
D
&
L
I
M
E
F
L
A
V
O
U
R
S
U
G
A
R
E
T
H
A
N
O
L
O%
M
A
D
E
I
N
T
H
E
F
R
E
E
F
R
E
E
U
K
Click here for 
Prescribing Information
S
U
I
T
A
B
L
E
F
O
R
V
E
G
E
T
A
S
N
R
I
A
13